Free Trial

Fideuram Asset Management Ireland dac Purchases Shares of 12,789 Veeva Systems Inc. $VEEV

Veeva Systems logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Fideuram Asset Management Ireland dac opened a new position in Veeva Systems in the fourth quarter, buying 12,789 shares worth about $2.86 million.
  • Institutional ownership in Veeva remains heavy, with 88.2% of the stock held by institutions and hedge funds. Several other investors also increased their stakes during the quarter.
  • Analyst sentiment is mixed but generally positive: Veeva carries a “Moderate Buy” consensus with a $276.52 average price target, even as some firms recently trimmed their targets or ratings.
  • MarketBeat previews the top five stocks to own by June 1st.

Fideuram Asset Management Ireland dac purchased a new stake in Veeva Systems Inc. (NYSE:VEEV - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 12,789 shares of the technology company's stock, valued at approximately $2,855,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of VEEV. National Pension Service boosted its holdings in shares of Veeva Systems by 7.4% in the fourth quarter. National Pension Service now owns 225,119 shares of the technology company's stock worth $50,253,000 after buying an additional 15,481 shares during the period. Linscomb Wealth Inc. boosted its holdings in shares of Veeva Systems by 2.3% in the fourth quarter. Linscomb Wealth Inc. now owns 13,207 shares of the technology company's stock worth $2,948,000 after buying an additional 301 shares during the period. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Veeva Systems by 14.1% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 5,171 shares of the technology company's stock worth $1,154,000 after buying an additional 638 shares during the period. Jupiter Asset Management Ltd. boosted its holdings in shares of Veeva Systems by 60.5% in the fourth quarter. Jupiter Asset Management Ltd. now owns 102,639 shares of the technology company's stock worth $22,912,000 after buying an additional 38,701 shares during the period. Finally, Huntington National Bank boosted its holdings in shares of Veeva Systems by 5.3% in the fourth quarter. Huntington National Bank now owns 2,084 shares of the technology company's stock worth $465,000 after buying an additional 105 shares during the period. 88.20% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have commented on VEEV shares. Morgan Stanley raised their target price on shares of Veeva Systems from $205.00 to $215.00 and gave the stock an "equal weight" rating in a report on Thursday, March 5th. Barclays decreased their target price on shares of Veeva Systems from $305.00 to $250.00 and set an "overweight" rating for the company in a report on Wednesday, February 25th. Needham & Company LLC decreased their target price on shares of Veeva Systems from $355.00 to $270.00 and set a "buy" rating for the company in a report on Thursday, March 5th. UBS Group raised their target price on shares of Veeva Systems from $200.00 to $220.00 and gave the stock a "neutral" rating in a report on Thursday, March 5th. Finally, Citigroup downgraded Veeva Systems from a "buy" rating to a "neutral" rating and dropped their target price for the company from $291.00 to $176.00 in a report on Friday, April 10th. Sixteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Veeva Systems currently has a consensus rating of "Moderate Buy" and a consensus price target of $276.52.

Read Our Latest Stock Analysis on VEEV

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

Insider Activity at Veeva Systems

In related news, Director Priscilla Hung sold 750 shares of the business's stock in a transaction that occurred on Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the completion of the sale, the director owned 3,253 shares of the company's stock, valued at approximately $506,296.92. The trade was a 18.74% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.60% of the company's stock.

Veeva Systems Price Performance

NYSE VEEV opened at $164.26 on Friday. The company has a 50 day simple moving average of $166.59 and a 200-day simple moving average of $199.95. The firm has a market capitalization of $26.83 billion, a price-to-earnings ratio of 30.36, a price-to-earnings-growth ratio of 0.70 and a beta of 0.92. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50.

Veeva Systems (NYSE:VEEV - Get Free Report) last posted its quarterly earnings results on Wednesday, March 4th. The technology company reported $2.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.94 by $0.12. The business had revenue of $835.95 million during the quarter, compared to analyst estimates of $810.95 million. Veeva Systems had a net margin of 28.44% and a return on equity of 13.80%. The firm's revenue was up 16.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.74 earnings per share. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. On average, analysts predict that Veeva Systems Inc. will post 6.45 EPS for the current year.

About Veeva Systems

(Free Report)

Veeva Systems NYSE: VEEV is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

Featured Stories

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veeva Systems Right Now?

Before you consider Veeva Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.

While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines